lerodalcibep-liga
lerodalcibep-liga is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including LEROCHOL. Available dosage form: injection, solution.
Drug Details
- Generic Name
- lerodalcibep-liga
- Brand Names
- LEROCHOL
- Application Number
- BLA761427
- Sponsor
- LIB Therapeutics, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- LERODALCIBEP
Indications and Usage
1 INDICATIONS AND USAGE LEROCHOL TM is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). LEROCHOL is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor indicated as an adjunct to diet and exercise: to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). ( 1 )